Des Jarlais D C, Friedman S R, Hopkins W
Ann Intern Med. 1985 Nov;103(5):755-9. doi: 10.7326/0003-4819-103-5-755.
Intravenous drug users are the second largest risk group for the acquired immunodeficiency syndrome (AIDS) and a bridge to two other groups: children and heterosexual partners. In the absence of effective treatment or vaccines, control of the epidemic among drug users will rely on efforts to reduce needle sharing. However, the traditional image of intravenous drug users leads one to expect little or no risk reduction. We review characteristics of AIDS as a disease that impede efforts at risk reduction among drug users and report on current risk reduction among intravenous drug users in New York City. There has been a sustained increase in the demand for new, unused needles, as shown in the emergence of "resealed" needles and in interviews with persons selling needles in illicit drug-purchasing areas.
静脉注射吸毒者是后天免疫机能丧失综合症（艾滋病）的第二大高危群体，并且是连接另外两个群体的桥梁：儿童和异性性伴侣。在缺乏有效治疗方法或疫苗的情况下，控制吸毒者中的艾滋病流行将依赖于减少共用针头的努力。然而，静脉注射吸毒者的传统形象使人预期几乎不会或根本不会降低风险。我们审视了艾滋病这种疾病的特征，这些特征阻碍了在吸毒者中降低风险的努力，并报告了纽约市静脉注射吸毒者目前降低风险的情况。对新的、未使用过的针头的需求持续增加，这体现在“重新封装”针头的出现以及在非法毒品购买地区对卖针头者的访谈中。
